Post Vaccination Adverse Events in Covid-19 Vaccine Recipients
NCT05254977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3515
Last updated 2022-04-13
Summary
Covid-19 pandemic is caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-Cov-2) since its outbreak 2019. Protection against Covid-19 can be achieved through global immunization. Various vaccines for SARS-Cov-2 has been registered and approved for administration in humans. It is important to understand the safety and efficacy of vaccines during robust research to develop global immunity against SARS-Cov-2. This study aimed to collect data on post vaccination adverse events in regional population of District Bahawalpur.
Conditions
- COVID-19 Vaccination
- Vaccine Adverse Reaction
Interventions
- DRUG
-
Standard Preparation
Any kind of intervention received to reduce adverse effects
Sponsors & Collaborators
-
District Health Authority (DHA) Bahawalpur District Bahawalpur, Government of Punjab.
collaborator UNKNOWN -
Islamia University of Bahawalpur
lead OTHER
Principal Investigators
-
Hafiz Abdul Sattar, M.Phil · Lecturer
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-26
- Primary Completion
- 2022-03-10
- Completion
- 2022-03-30
Countries
- Pakistan
Study Locations
More Related Trials
-
Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians
NCT04706143 ·Status: UNKNOWN
-
A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women
NCT01354730 ·Status: COMPLETED
-
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
NCT02567721 ·Status: COMPLETED
-
The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal LAIV Mucosal Immunity Examination
NCT07093281 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)
NCT03392207 ·Status: COMPLETED
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years
NCT00952419 ·Status: COMPLETED ·Phase: PHASE2
-
Post-License Safety Evaluation of Influenza Virus Vaccine
NCT02136017 ·Status: COMPLETED
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
NCT05115370 ·Status: COMPLETED
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
NCT03278067 ·Status: COMPLETED
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
NCT01101074 ·Status: COMPLETED
-
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
NCT05078905 ·Status: RECRUITING
-
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
NCT01622491 ·Status: UNKNOWN
-
Influenza Vaccination After Acute Coronary Syndrome
NCT07259252 ·Status: RECRUITING ·Phase: NA
-
Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
NCT05095298 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
NCT04508075 ·Status: COMPLETED ·Phase: PHASE3
-
Covid-19 and Influenza Oral Vaccine Study
NCT06355232 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly
NCT00954798 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00968539 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes
NCT03654937 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
NCT01053143 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23
NCT05568979 ·Status: COMPLETED